The New Zealand contracts being negotiated might relate to the announcement made 30th October last year (when ticker code was still NRR)
"......Alcidion was successful in securing a preferred vendor status for a Patient Flow Solution in New Zealand. The securing of this tender was a significant milestone as the project was won against fierce competition from two New Zealand based organizations."
It stands to reason that this tender was secured by Alcidion as a result of having a superior product and service.
My guess is that that we will receive some very positive announcements regarding new contracts and progress towards securing new contracts quite soon after the shares become available for trading. The company would not be able to secure the presence (and endorsement) of all these political and industry heavyweights at its recent and upcoming functions and roadshow presentations unless the company's products were the real deal with real potential for worldwide success.
ALC Price at posting:
5.6¢ Sentiment: Buy Disclosure: Held
